Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine

European Journal of Pharmacology

Volumn 525, Issue 1-3, 2005, Pages 98-104

  Panchal, Vishal ^a   Taraschenko, Olga D ^a   Maisonneuve, Isabelle M ^a   Glick, Stanley D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Interpeduncular nucleus; Locus coeruleus; Medial habenula; Morphine; Naltrexone; Physical dependence

Indexed keywords

18 METHOXYCORONARIDINE; MORPHINE; NALTREXONE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURYING; CONTROLLED STUDY; DIARRHEA; DISEASE EXACERBATION; FEMALE; HABENULA; INTERPEDUNCULAR NUCLEUS; LOCUS CERULEUS; NONHUMAN; PRIORITY JOURNAL; RAT; TEETH CHATTERING; WEIGHT REDUCTION; WET DOG SHAKES; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN; DRUG ADMINISTRATION ROUTES; FEMALE; IBOGAINE; LOCUS COERULEUS; MORPHINE; MORPHINE DEPENDENCE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 28044434214     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.09.060     Document Type: Article

References (47)

1. M.C. Almeida, A.A. Steiner, N.C. Coimbra, and L.G. Branco Thermoeffector neuronal pathways in fever: a study in rats showing a new role of the locus coeruleus J. Physiol. 558 2004 283 294
2. T. Antonelli, L. Beani, C. Bianchi, S. Rando, M. Simonato, and S. Tanganelli Cortical acetylcholine release is increased and gamma-aminobutyric acid outflow is reduced during morphine withdrawal Br. J. Pharmacol. 89 1986 853 860
3. G. Aston-Jones, M.T. Shipley, G. Chouvet, M. Ennis, E. van Bockstaele, V. Pieribone, R. Shiekhattar, H. Akaoka, G. Drolet, and B. Astier Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology Prog. Brain Res. 88 1991 47 75
4. A.A. Baumeister, A.L. Richard, L. Richmond-Landeche, M.J. Hurry, and A.M. Waguespack Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome Neuropharmacology 31 1992 835 841
5. H.N. Bhargava, and E.L. Way Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists Eur. J. Pharmacol. 36 1976 79 88
6. J.J. Buccafusco Inhibition of the morphine withdrawal syndrome by a novel muscarinic antagonist (4-DAMP) Life Sci. 48 1991 749 756
7. J. Carlson, B. Armstrong, R.C. Switzer III, and G. Ellison Selective neurotoxic effects of nicotine on axons in fasciculus retroflexus further support evidence that this a weak link in brain across multiple drugs of abuse Neuropharmacology 39 2000 2792 2798
8. J. Carlson, K. Noguchi, and G. Ellison Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus Brain Res. 906 2001 127 134
9. D.L. Cheney, M. Trabucchi, G. Racagni, C. Wang, and E. Costa Effects of acute and chronic morphine on regional rat brain acetylcholine turnover rate Life Sci. 15 1974 1977 1990
10. J. Crossland, and K.Z. Ahmed Brain acetylcholine during morphine withdrawal Neurochem. Res. 9 1984 351 366
11. J.B. Dean, and J.A. Boulant Effects of synaptic blockade on thermosensitive neurons in rat diencephalon in vitro Am. J. Physiol. 257 1989 R65 R73
12. G. Ellison Continuous amphetamine and cocaine have similar neurotoxic effects in lateral habenular nucleus and fasciculus retroflexus Brain Res. 598 1992 353 356
13. G. Ellison Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry Eur. Neuropsychopharmacol. 12 2002 287 297
14. J.D. Fryer, and R.J. Lukas Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine J. Pharmacol. Exp. Ther. 288 1999 88 92
15. M. Funada, C. Hara, and K. Wada Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system Eur. J. Pharmacol. 430 2001 277 281
16. S.D. Glick, M.E. Kuehne, I.M. Maisonneuve, U.K. Bandarage, and H.H. Molinari 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats Brain Res. 719 1996 29 35
17. S.D. Glick, I.M. Maisonneuve, and H.A. Dickinson 18-MC reduces methamphetamine and nicotine self-administration in rats NeuroReport 11 2000 2013 2015
18. S.D. Glick, I.M. Maisonneuve, B.A. Kitchen, and M.W. Fleck Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration Eur. J. Pharmacol. 438 2002 99 105
19. S.D. Glick, I.M. Maisonneuve, and B.A. Kitchen Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha3beta4 nicotinic receptors Eur. J. Pharmacol. 448 2002 185 191
20. M.L. Gonzalvez, M.V. Milanes, M.G. Martinez-Pinero, M.T. Marin, and M.L. Vargas Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal Brain Res. 647 1994 199 203
21. R. Grzanna, and J.M. Fritschy Efferent projections of different subpopulations of central noradrenaline neurons Prog. Brain Res. 88 1991 89 101
22. Guide for the Care and Use of Laboratory Animals Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council 1996 National Academy Press Washington, D.C.
23. S.C. Hernandez, M. Bertolino, Y. Xiao, K.E. Pringle, F.S. Caruso, and K.J. Kellar Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors J. Pharmacol. Exp. Ther. 293 2000 962 967
24. L.N. Holland, L.C. Shuster, and J.J. Buccafusco Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat Neuropharmacology 32 1993 1387 1395
25. D.M. Ignar, and C.M. Kuhn Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat J. Pharmacol. Exp. Ther. 255 1990 1287 1295
26. K. Jhamandas, and M. Sutak Modification of brain acetylcholine release by morphine and its antagonists in normal and morphine-dependent rats Br. J. Pharmacol. 50 1974 57 62
27. A.S. Kimes, J.A. Bell, and E.D. London Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal Neuroscience 34 1990 633 644
28. G.F. Koob, R. Maldonado, and L. Stinus Neural substrates of opiate withdrawal Trends Neurosci. 15 1992 186 191
29. I.M. Maisonneuve, and S.D. Glick Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment Pharmacol. Biochem. Behav. 75 2003 607 618
30. R. Maldonado, L. Stinus, L.H. Gold, and G.F. Koob Role of different brain structures in the expression of the physical morphine withdrawal syndrome J. Pharmacol. Exp. Ther. 261 1992 669 677
31. M.V. Milanes, M.L. Laorden, M. Chapleur-Chateau, and A. Burlet Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response J. Pharmacol. Exp. Ther. 285 1998 700 706
32. B.J. Morley The interpeduncular nucleus Int. Rev. Neurobiol. 28 1986 157 182
33. R.F. Mucha What is learned during opiate withdrawal conditioning? Evidence for a cue avoidance model Psychopharmacology (Berl.) 104 1991 391 396
34. R.L. Papke, P.R. Sanberg, and R.D. Shytle Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes J. Pharmacol. Exp. Ther. 297 2001 646 656
35. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates Second ed. 1986 Academic Press Inc. San Diego, CA
36. D.C. Perry, Y. Xiao, H.N. Nguyen, J.L. Musachio, M.I. Davila-Garcia, and K.J. Kellar Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography J. Neurochem. 82 2002 468 481
37. M.W. Quick, R.M. Ceballos, M. Kasten, J.M. McIntosh, and R.A. Lester Alpha3beta4 subunit-containing nicotinic receptors dominate function in rat medial habenula neurons Neuropharmacology 38 1999 769 783
38. P. Rada, E. Pothos, G.P. Mark, and B.G. Hoebel Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine Brain Res. 561 1991 354 356
39. P.V. Rada, G.P. Mark, K.M. Taylor, and B.G. Hoebel Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex Pharmacol. Biochem. Behav. 53 1996 809 816
40. B. Rho, and S.D. Glick Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats NeuroReport 9 1998 1283 1285
41. L.A. Smaha, and W.W. Kaelber Efferent fiber projections of the habenula and the interpeduncular nucleus. An experimental study in the opossum and cat Exp. Brain Res. 16 1973 291 308
42. R.J. Sutherland The dorsal diencephalic conduction system: a review of the anatomy and functions of the habenular complex Neurosci. Biobehav. Rev. 6 1982 1 13
43. Y. Tache, V. Martinez, L. Wang, and M. Million CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome Br. J. Pharmacol. 141 2004 1321 1330
44. O.D. Taraschenko, V. Panchal, I.M. Maisonneuve, and S.D. Glick Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence? Eur. J. Pharmacol. 513 2005 207 218
45. J.R. Taylor, J.D. Elsworth, E.J. Garcia, S.J. Grant, R.H. Roth, and D.E. Redmond Jr. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal Psychopharmacology (Berl.) 96 1988 121 134
46. S. Wonnacott Presynaptic nicotinic ACh receptors Trends Neurosci. 20 1997 92 98
47. G.F. Wooten, P. DiStefano, and R.C. Collins Regional cerebral glucose utilization during morphine withdrawal in the rat Proc. Natl. Acad. Sci. U. S. A. 79 1982 3360 3364